Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 1

Optimal timing for antihypertensive dosing: focus on valsartan

       
Total article views   HTML views PDF downloads Totals
6,782 Dovepress* 6,782+ 2,006 8,788
Totals 6,782 2,006 8,788
*Since 15 March 2007
+Since July 2016

View citations on Google Scholar